1. Home
  2. YORW vs ENTA Comparison

YORW vs ENTA Comparison

Compare YORW & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo York Water Company (The)

YORW

York Water Company (The)

HOLD

Current Price

$32.66

Market Cap

471.4M

Sector

Utilities

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.46

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YORW
ENTA
Founded
1816
1995
Country
United States
United States
Employees
104
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
471.4M
486.3M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
YORW
ENTA
Price
$32.66
$13.46
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
70.3K
184.0K
Earning Date
06-08-2026
05-11-2026
Dividend Yield
2.80%
N/A
EPS Growth
N/A
29.93
EPS
1.39
N/A
Revenue
$77,488,000.00
$102,814,000.00
Revenue This Year
$9.74
$5.91
Revenue Next Year
$7.89
N/A
P/E Ratio
$23.54
N/A
Revenue Growth
3.37
16.48
52 Week Low
$29.68
$4.09
52 Week High
$36.48
$17.15

Technical Indicators

Market Signals
Indicator
YORW
ENTA
Relative Strength Index (RSI) 46.15 44.83
Support Level $31.23 $13.39
Resistance Level $32.98 $13.98
Average True Range (ATR) 0.63 0.86
MACD -0.03 -0.03
Stochastic Oscillator 32.18 15.79

Price Performance

Historical Comparison
YORW
ENTA

About YORW York Water Company (The)

The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: